Navigation Links
Akonni Biosystems Elects Brian J. Morra as Executive Chairman of the Board
Date:7/5/2017

Akonni Biosystems, a molecular diagnostics (MDx) company that develops, manufactures, and intends to market advanced MDx systems, today announced the election of Mr. Brian J. Morra as the company’s Executive Chairman of the Board of Directors. His election highlights the company’s commitment to succeeding in the next phase of its corporate development. In his new role, Mr. Morra will lead the Board of Directors and provide crucial operational support to Akonni’s Founder and CEO, Dr. Charles Daitch. He will work closely with the Board, senior management, and other key stakeholders to ensure the company’s financial and operational posture enables it to meet its strategic corporate objectives and build shareholder value.

Mr. Morra was a senior executive in two entrepreneurial firms that each had highly successful liquidity events. As a senior vice president at Pacific-Sierra Research Corporation (PSR) he was instrumental in the company’s successful all-cash sale to Veridian. As a sector president at Veridian, Mr. Morra was an integral player in the company’s M&A strategy, culminating in several acquisitions and their integration into the firm. Veridian subsequently conducted a successful IPO in 2002 and was acquired by General Dynamics in 2003. Daitch worked for and was mentored by Morra at PSR and Veridian. Daitch’s biological detection business unit played a key role in the acquisition of PSR by Veridian for $55M in 1998 and became one of the 5 key pillars to Veridian’s successful 2002 IPO raising $213M (market cap $495M). Daitch exclaimed, “Brian and I have worked synergistically together for over 20 years and I am looking forward to us working together again to add to our track record of successes.”

After joining Northrop Grumman Corporation in 2004, Mr. Morra was appointed as Sector Vice President and capitalized on his entrepreneurial expertise to lead several M&A actions and strategic equity investments in small businesses in the United States and abroad. His expertise in small businesses enabled him to serve on the board of directors of Northrop Grumman acquisitions and to guide those companies through their integration into the company. Mr. Morra also led half a dozen divestiture actions all of which delivered significant value, while improving Northrop Grumman’s portfolio focus. Mr. Morra’s entrepreneurial experience and expertise in strategic planning, M&A, divestiture, and strategic equity investments was used extensively across the entirety of Northrop Grumman and highly valued by the top leadership of the company.

Mr. Morra served nine years as a regular officer in the United States Air Force, has a BA degree from the College of William and Mary, an MPA from Oklahoma University and an MA from Georgetown University. He is also a graduate of the Advanced Management Program at Harvard Business School.

For more information visit: http://www.akonni.com.

About Akonni Biosystems
Akonni Biosystems was founded in 2003 and has 17 US and 24 International issued patents primarily covering sample preparation, microfluidic devices, bio-instrumentation, and integrated systems. Product development has been supported by a series of government grants and contracts from NIH, CDC, DOE, DOD, NIJ, and NSF. The company significantly advanced the original technology by improving the system’s capabilities from sample preparation to test result. Commercial products in Akonni’s near-term pipeline include rapid sample preparation technologies for nucleic acid extraction and multiplex panel assays for detecting clinically relevant genotypes for pharmacogenomics, human chronic diseases (i.e. cancer and neurodegenerative), and genotypes for infectious diseases such as multidrug-resistant tuberculosis (MDR-TB), extensively drug-resistant tuberculosis (XDR-TB), upper respiratory infections, viral encephalitis, and hospital-acquired infections (MRSA).

Read the full story at http://www.prweb.com/releases/2017/07/prweb14478028.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Akonni Biosystems Awarded Grant to Validate TruTip® Sample Preparation Technology for Use in Low Resource Settings
2. Cynvenio Biosystems to Present Clinical Data on Mutational Analysis of LiquidBiopsy® Tumor Samples at the 2013 ASCO Annual Meeting
3. Leica Biosystems übernimmt Kreatech Diagnostics
4. Cynvenio Biosystems Receives CLIA Certification for its Genomic Sequencing Laboratory
5. Indigo BioSystems, Inc. Ranks in the 2013 Inc. 500
6. 5000 for America's Fastest Growing Companies
7. Silicon Biosystems Appoints Farideh Bischoff, Ph.D. as Executive Director of Scientific Affairs
8. Diagnostic BioSystems Raises Growth Capital and Expands Facility and Management Team to Support Continued Growth
9. Silicon Biosystems, Syracuse University Form Forensic Tech Alliance
10. Leica Biosystems and Cockerell Dermatopathology Partner to Improve the Patient Experience Through Innovation With Aperio Digital Pathology*
11. Dr. Michael A. Pfaller of T2 Biosystems to Discuss the Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship in New Webinar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... (PRWEB) , ... August 08, ... ... its industry leading Bolt-on CMC™ expert services platform by combining its deep ... convenient, cost-effective approach to help you meet periodic pharmaceutical GxP training requirements. ...
(Date:8/9/2018)... ... August 09, 2018 , ... MedEvolve, Inc. , ... and analytics software and services for physician practices, announced today the company’s bookings ... After back-to-back record quarters in Q2 and Q3 last year, the company has ...
(Date:8/7/2018)... ... ... PetPace , the makers of a smart health-monitoring collar for pets, and ... a groundbreaking study to identify and eventually predict problems and complications affecting pregnant dogs. ... by PetPace and conducted by Dr. Smadar Tal, DVM, DACT, DECAR, a veterinarian specializing ...
(Date:7/31/2018)... , ... July 31, 2018 , ... ... for 65 years, announces the launch of their new website. The new website ... experience throughout the site. Mahoney partnered with Proceed Innovative to build a website ...
Breaking Biology Technology:
(Date:7/29/2018)... ... 29, 2018 , ... Dr. William Plikerd, an evidence-based energy healer, today announces ... immunity and to combat inflammation and autoimmune disorders. , The preclinical research assessed ... reported:, Up to 260% increase overall immunity as seen ...
(Date:7/28/2018)... ... July 28, 2018 , ... ... Hong Kong Polytechnic University (PolyU), has been honoured with the International Association for ... field of wind engineering and bridge engineering in research, education, and application. Professor ...
(Date:7/26/2018)... ... , ... Boston Biotech Conferences will host BD Boston, an ... Hilton Boston Back Bay Hotel. This peer-to-peer meeting provides an opportunity for industry ... relevant deals in biotech. , George Golumbeski recently joined GRAIL with more than ...
Breaking Biology News(10 mins):